Abstract:Introduction No-test telehealth medication abortion reduces or eliminates pre-abortion ultrasound and in-person testing and is proving to be as safe, acceptable, and effective as in-person care. However, ectopic pregnancy remains a primary concern about the telehealth model. Ectopic pregnancy is a rare but serious life-threatening pregnancy complication, and we lack evidence about how ectopic pregnancies are diagnosed and treated in the no-test telehealth context. Filling a notable research gap, we describe the clinical presentation and experiences of people seeking telehealth medication abortion who were subsequently suspected or confirmed to have had an ectopic pregnancy. Method From June 2022 through March 2023, we recruited patients who sought medication abortion from January 2022-March 2023 at seven virtual telehealth abortion clinics in the U.S. who were suspected or confirmed to have had an ectopic pregnancy. Clinics shared an eligibility survey link with patients with a suspected ectopic pregnancy. People who were eligible and interested in participating scheduled an interview with a researcher. Interviews were conducted over the phone, audio recorded, and transcribed and lasted approximately 45 minutes (range 35-80 minutes). We used an iterative grounded theory approach to analyze interview transcripts and identify salient themes. Results We interviewed 15 people ages 21-41 living in 11 states; 14 had a confirmed ectopic pregnancy (11 located in the fallopian tube, 2 cesarean scar, and 1 unconfirmed location). People chose telehealth abortion care because of its privacy, affordability, convenience or because it was their only option. When presenting for abortion care, most had no ectopic pregnancy symptoms or risk factors. Two had spotting and one had an IUD removed earlier in the pregnancy by her primary care provider, who did not diagnose the ectopic with ultrasound and told her the pregnancy was "where it should be." Seven never took the medications because they experienced bleeding, pain symptoms, and/or were referred for ectopic pregnancy care by the telehealth provider. One participant with symptoms chose not to take the medications because her OB/GYN who performed an ultrasound told her she was not pregnant. Among the people who took the medications, all experienced no or light bleeding after taking the medications and 4 experienced excruciating or "dull" abdominal pain leading them to seek further care. Participants perceived telehealth abortion care to sometimes facilitate earlier ectopic pregnancy treatment and perceived ectopic pregnancy care to be fragmented and to sometimes delay treatment. Conclusions Findings suggest that no-test telehealth abortion care does not delay and sometimes facilitates earlier detection and treatment of ectopic pregnancy. Reliance on ultrasound does not eliminate the risk of missed ectopic pregnancy. Fragmented care and ultrasounds that miss the ectopic pregnancy can lead to ectopic pregnancy treatment delays. Strategies are needed to address challenges experienced with fragmented care to facilitate timely diagnosis and treatment of ectopic pregnancy.

Abortion pills on TV: An exploratory study of the associations between abortion plotline viewership and beliefs regarding in-clinic and self-managed medication abortion

Abortion in entertainment media, 2019-2024

Feeling better: representing abortion in 'feminist' television

Interest in advance provision of abortion pills: a national survey of potential users in the USA

'The abortion gave me my life back': the long-term impact of access to self-managed medication abortion through telemedicine on women's lives in legally restricted countries

Comparison of No-Test Telehealth and In-Person Medication Abortion

Medication and procedural abortion uptake during a period of increasing abortion hostility

Patient Acceptability of Telehealth Medication Abortion Care in the United States, 2021‒2022: A Cohort Study

Determinants of Unsupervised Medical Termination of Pregnancy Pill Usage Among Women: A Cross-Sectional Study From North India

Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product

Patient Perspectives Regarding Clinician Communication During Telemedicine Compared With In-Clinic Abortion

Effectiveness and safety of telehealth medication abortion in the USA

Accuracy, Quality, and Misinformation of YouTube Abortion Procedural Videos: Cross-Sectional Study

Telemedicine Abortion in Primary Care: An Exploration of Patient Experiences

Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women’s Health Organization Decision

Experiences of Ectopic Pregnancy Among People Seeking Telehealth Abortion Care

The perceived impact of a post-Dobbs landscape on U.S. adolescents and young adults

Primary Care Clinicians' Interest In, and Barriers To, Medication Abortion

"Trust Women": Characteristics of and learnings from patients of a Shield Law medication abortion practice in the United States

The role of community and culture in abortion perceptions, decisions, and experiences among Asian Americans

Role of Medical Treatment in Abortion-An Observational Study